Human immunodeficiency virus type 1 (HIV-1) and HIV-2 enter cells by pH-independent fusion of their envelopes with cellular membranes (reviewed in references 27 and 35) . Fusion is mediated by the envelope glycoprotein of the virus, which consists of two subunits, gp120 and gp41, derived from a single precursor, gp160 (35) . The gp41, or transmembrane, subunit is an integral membrane protein with a C-terminal cytoplasmic domain, a membrane anchor, and, at its N terminus, a hydrophobic ''fusion'' peptide (4, 11, 26) . The gp120, or surface, subunit is a soluble protein which remains noncovalently bound to gp41 following proteolytic cleavage of the gp160 precursor. During infection, gp120 binds to receptors, frequently CD4, on the surface of the target cell (7, 25, 31, 33) . Following binding, mechanisms are set in progress that enable the gp120-gp41 complex to induce fusion of the viral and cellular membranes. By analogy to influenza virus, HIV fusion is believed to require a series of conformational changes in the envelope protein complex that lead to exposure of the putative fusion peptide (reviewed in references 10 and 35). For certain HIV strains, CD4 binding may itself induce conformational changes in the gp120-gp41 complex which can result in dissociation of gp120 from gp41 (10, 17, 38, 45) . However, it is unclear whether these changes are involved in fusion, and a detailed understanding of the HIV fusion reaction remains to be established.
Cells expressing cloned HIV-1 gp120-gp41 complexes on their surface can fuse specifically with CD4-expressing cells (29, 46) . These fusion reactions, which result in the formation of large, multinuclear syncytia, can provide valuable models for virus-cell fusion. Moreover, gp120-gp41-mediated fusion of infected cells with bystander cells to form multinuclear syncytia can also contribute to the pathogenic effects of HIV (55) . Recently, Fu et al. (12) investigated the syncytium formation of cells expressing gp120-gp41 with CD4-expressing cells, and they found that CD4-induced dissociation of the gp120-gp41 complex and shedding of gp120 do not trigger fusion but could instead inactivate the fusion activity of the CD4-gp120-gp41 complex. Although there is independent evidence that supports this hypothesis (51) , the conclusions of Fu et al. (12) were based on the temperature and pH dependence of gp120 shedding and syncytium formation.
Here, we report that gp120-gp41-mediated syncytium formation with CD4-expressing cells does not take place below 25ЊC, confirming the results of Fu et al. (12) . Since the detection of fusion by syncytium formation requires rearrangement of the nuclei of the fused cells, we have sought to confirm these results by a novel fluorescence-based assay for lipid mixing. No lipid mixing was detected below 25ЊC, indicating that fusion did not take place below that temperature. We investigated the reason for this and found that the temperature dependence of fusion correlated with that of cell-cell binding; some gp120-CD4-specific cell-cell binding was seen at all temperatures, but there was a three-to fourfold increase above 25ЊC. Cell-cell binding and fusion at 37ЊC were reduced by cytochalasins B and D. Taken together, these data suggest that a cytoskeletondependent increase in the avidity of binding of gp120-gp41-expressing cells with CD4-bearing cells occurs. Most likely, the increased avidity is due to an increased number of CD4-gp120 contacts, suggesting that the formation of a fusion complex containing multiple gp120-gp41 and CD4 molecules is required for fusion.
MATERIALS AND METHODS
Cells and virus. CHO K1 cells were transfected with a derivative of the EE6 expression vector (50) containing a Sal1-Xho1 fragment (coordinates 5365 to 8479 [42] ) from the BH-10 strain of HIV-1 IIIB. This fragment includes the complete env gene together with the tat, rev, and vpu genes. Coordinate expression of these genes was from the human cytomegalovirus major immediate-early promoter. In addition, this vector contained the glutamine synthetase gene as a selectable marker (2) . Following transfection, stable cell lines were selected and maintained in glutamine-free Glasgow modified Eagle minimal medium supplemented with L-methionine sulfoximine (200 M) and 10% dialyzed fetal calf serum (FCS) (2) . These lines were subcloned several times, and the clones showing the highest syncytium-forming activity with SupT1 cells were selected at each round. For experiments, cells were maintained in selection for 20 passages. Nontransfected CHO K1 cells were maintained in the same medium but without L-methionine sulfoximine and with 2 mM L-glutamine. SupT1 cells and RPMI cells (human CD4-expressing and CD4-negative T-lymphoblastic cell lines, respectively) were grown in suspension in RPMI 1640 medium supplemented with 10% FCS and 2 mM glutamine. BHK-21 cells were grown in Dulbecco's modification of Eagle's minimal essential medium supplemented with 10% tryptose phosphate broth, 5% FCS, and 2 mM glutamine. HeLa-CD4 cells, obtained from V. Bosch, Deutsches Krebsforschungszentrum, Heidelberg, Germany, were maintained in the same medium but without tryptose phosphate broth. Cytochalasins B and D were from Sigma. Nucleosides were from Fluka (Buchs, Switzerland), and all other ingredients were from GIBCO BRL (Basel, Switzerland).
The X-31 recombinant strain of influenza virus was grown for us by the Swiss Institute for Serum and Vaccines (Bern, Switzerland) in embryonated eggs and purified, handled, and stored as previously described (47) . gp160 and gp120-gp41 expression. For indirect immunofluorescence, CHOgp160 cells were fixed with 3% paraformaldehyde at room temperature for 15 min. Expression of gp41 was assayed by using monoclonal antibody NEA-9303 (NEN, DuPont, Regensdorf, Switzerland), followed by a rhodamine-conjugated goat anti-mouse immunoglobulin G antibody (Cappel-Organon Technika, Pfäf-fikon, Switzerland). Both antibodies were used at a dilution of 1:100. gp160 and both subunits of the processed form, gp120 and gp41, were detected on Western blots (immunoblots) with a rabbit anti-gp160 antiserum obtained from V. Bosch and a goat anti-rabbit secondary reagent conjugated with alkaline phosphatase (Dianova, Hamburg, Germany).
Syncytium assays. Syncytium formation was measured as follows. SupT1 or RPMI cells (10 6 ) were added to 90% confluent CHO-gp160 cells grown on 35-mm-diameter tissue culture dishes. Alternatively, CHO-gp160 cells grown on 12-mm-diameter glass coverslips were placed in 24-well tissue culture plates and overlaid with 2.5 ϫ 10 5 SupT1 or RPMI cells. Samples were incubated for 3 to 5 h at the temperatures indicated elsewhere in this report, washed to remove free cells, fixed with ice-cold methanol, and stained with Giemsa (Fluka).
For syncytium formation induced by influenza virus (fusion from without), 90% confluent BHK-21 cells grown on 60-mm-diameter tissue culture dishes were washed with phosphate-buffered saline (PBS) containing Ca 2ϩ and Mg 2ϩ (PBS 2ϩ ) and overlaid with 1 ml of PBS 2ϩ containing approximately 60 g of influenza virus. The plates were gently rocked at 4ЊC for 1 h, after which the virus was aspirated and 3 ml of buffer at the appropriate pH and temperature was added. The dishes were incubated for 5 min at the temperatures indicated elsewhere in this report, the buffer was then replaced by medium, and the cells were incubated at the temperature indicated elsewhere in this report for a further 2 to 5 h. The cells were then fixed and stained as described above. When incubations at a low pH were carried out for much longer than 5 min, the resulting fusion index was lower. Below 20ЊC, syncytium formation could not be measured because the cells tended to round up and aggregate, especially after low-pH treatment.
To quantitate cell-cell fusion, cells and nuclei were counted and a fusion index was calculated as follows: 1 Ϫ (number of cells/number of nuclei) (56) . A minimum of 500 nuclei were counted per datum point.
Metabolic labeling of SupT1 cells with fluorescent lipids. The fluorescent fatty acid 4,4-difluoro-5,5-dimethyl-4-bora-3a,4a-diaza-3-indacene undecanoic acid (BODIPY-FL C 11 ) (22) , kindly provided by Molecular Probes (Eugene, Oreg.), was kept as a stock solution in ethanol. SupT1 cells were seeded at 10 5 /ml in medium containing 2 g of BODIPY-FL C 11 per ml and grown for 3 days. The cells were washed several times, and the remaining nonmetabolized fatty acids were removed from the cells by incubation in fresh medium containing FCS for at least 30 min at 37ЊC.
Cell-cell binding. CHO-gp160 and CHO K1 cells on coverslips were put into 24-well plates. BODIPY-FL C 11 labeled SupT1 cells (2.5 ϫ 10 5 ) were added, and the plates were incubated for 3 to 5 h. The coverslips were washed with PBS 2ϩ to remove unbound SupT1 cells, and the remaining cells were lysed with 1% Triton X-100 (Sigma). Fluorescence intensities were measured in a Jasco FP777 fluorimeter at an excitation wavelength of 495.0 nm and an emission wavelength of 512.5 nm. A 495-nm cutoff filter was placed between the sample and the emission monochromator to minimize the effects of light scattering. To probe for fusion specificity, we used a chimeric molecule constructed from the gp120-binding domain of CD4 but with a human Fc tail (CD4H␥3) (52, 53 I-labeled gp120 to SupT1 cells at several different temperatures was measured as follows. SupT1 cells (10 6 ) were washed in BM and labeled with 3.1 nM 125 I-labeled gp120 in BM for 2 h at temperatures indicated elsewhere in this report. Cells were collected by centrifugation, and an aliquot of the supernatant was counted for estimation of the free 125 I-labeled gp120 concentration. Cells were washed twice in BM and then layered onto 1 ml of 5% BSA in PBS. After centrifugation (1,000 ϫ g, 5 min), the supernatants were discarded and the cell pellets were counted. For nonspecific-binding controls, 125 I-labeled gp120 was incubated with SupT1 cells together with a 20-fold molar excess of an anti-CD4 antibody, Q4120 (19) , which inhibits CD4-gp120 binding.
RESULTS
Temperature dependence of cell-cell fusion induced by the envelope glycoprotein of HIV. CHO cells stably transfected with the complete envelope gene of HIV-1 strain IIIB (CHOgp160) and selected for fusion competence with SupT1 cells were assayed for cell surface HIV-1 envelope protein expression by indirect immunofluorescence by using a monoclonal antibody against gp41 (see Materials and Methods). More than 50% of the cells displayed detectable specific cell surface fluorescence (data not shown). In contrast, untransfected CHO K1 cells were not stained. The expression of gp160 and both subunits of the processed form of the envelope protein, gp120 and gp41, was analyzed on Western blots of CHO-gp160 cell lysates by using a rabbit anti-gp160 antibody (data not shown). gp160, gp120, and gp41 were all observed in CHO-gp160 cell lysates but not in lysates from CHO K1 cells, indicating that the gp160 protein was expressed and correctly cleaved. The membrane fusion activity of the expressed protein was measured by monitoring the ability of CHO-gp160 cells to form syncytia with CD4-positive SupT1 cells. At 37ЊC, large syncytia were observed when CHO-gp160 cells were cocultured with SupT1 cells (Fig. 1 ). Syncytia were not observed when CHOgp160 cells were cocultured with CD4-negative RPMI cells, cell was determined. No significant syncytium formation was detected during the first 20 min at 37ЊC (Fig. 2) . However, by 30 min after addition of SupT1 cells, multinuclear cells were observed. The fusion index increased with time to a maximum of 0.4 to 0.5 at about 2 h. Subsequently, no further increase in the number of nuclei per cell was seen.
To determine the temperature dependence of syncytium formation, CHO-gp160 cells were overlaid with SupT1 cells and incubated at the temperatures indicated for 3 h. Extensive syncytium formation was observed in the range of 30 to 42ЊC (Fig. 3 ), but the fusion index remained at background levels at temperatures of 25ЊC and below, confirming the results of Fu et al. (12) . At 20ЊC, no syncytium formation was observed, even after 60 h. However, multinuclear syncytia were observed when, after this time, the cultures were shifted to 37ЊC, and 3 to 5 h after the shift, the fusion index was 0.4 to 0.5. These results suggest that the lack of syncytium formation at 20ЊC reflects inhibition of fusion at low temperatures.
For membrane fusion to be detected by syncytium formation, cells not only need to fuse their plasma membranes but must also undergo major structural reorganizations that collect the nuclei in the center of the syncytium. Thus, the observed temperature dependence of syncytium formation could occur at the level of postfusion cellular reorganization and be independent of fusion per se. Therefore, an assay for lipid mixing was developed which allowed the fusion reaction to be detected directly. Existing assays are usually based on the fluorescent probe octadecylrhodamine (R18). We have previously found that R18 dequenching can occur through molecular exchange between membranes rather than through membrane fusion (48) and also noticed an exchange between SupT1 and CHO cells in pilot experiments. As an alternative to R18, we examined fusion by using fluorescent phospholipids which cannot readily exchange between membranes.
Since membranes do not take up significant amounts of exogenously added phospholipids spontaneously, we labeled the phospholipids of SupT1 cells by metabolic incorporation of a fluorescent fatty acid. SupT1 cells in the mid-log phase were supplied with the fluorescent fatty acid BODIPY-FL C 11 (22) and grown for 3 days. The amount of fluorophore incorporated per cell varied somewhat. The cells incorporated about 1% of the fluorescent fatty acid into phospholipids, predominantly into phosphatidylcholine (data not shown). All cellular membranes were labeled by the fluorescent lipids. After labeling, the free fluorescent fatty acid was removed by incubating the cells in medium containing FCS. For fusion, fluorescent SupT1 cells were added to CHO-gp160 cells or to untransfected CHO K1 cells. If fusion would give rise to lipid mixing before syncytium formation became apparent, the CHO-gp160 cells participating in a fusion event should become fluorescent and later fluorescent syncytia should appear. To test this assumption, the time needed to detect fusion by the appearance of fluorescent CHO-gp160 cells was compared to the time needed for syncytium formation. At 37ЊC, lipid mixing events were detectable after incubation times as brief as 10 min (Fig. 4, arrow) and at least 20 min before the earliest appearance of syncytia (Fig. 2) . After 2 h, all syncytia were fluorescent and some SupT1 cells that remained bound but were not fused were observed (Fig.  4) . No significant transfer of fluorescence to cells that were not in syncytia was observed, nor were untransfected CHO K1 cells labeled after incubation with fluorescent SupT1 cells, indicating that transfer of the probe from SupT1 to CHO cells required membrane fusion and did not occur through molecular exchange of lipids between the cells. Therefore, this assay reliably detects fused cells. Fluorescent SupT1 cells were observed to bind to CHO-gp160 cells throughout the 0 to 42ЊC temperature range. However, fusion was observed only at temperatures in excess of 25ЊC, even after incubation for 60 h. These data confirm that membrane fusion did not occur at temperatures of 25ЊC and below.
In the experiments described thus far, CD4-expressing cells grown in suspension were added to CHO-gp160 cells grown on dishes. To investigate whether the observed temperature dependence was a property of such systems rather than a feature of gp120-gp41-induced cell-cell fusion, syncytium formation was measured in cocultures of CD4-expressing HeLa (HeLa- (Table 1) . Whether HeLa-CD4 cells were first plated and then overlaid with CHO-gp160 cells or the other way around, cell-cell fusion was found after overnight incubation at 37ЊC. In contrast, incubation for 6 days at 25ЊC did not result in significant syncytium formation. However, it should be noted that at 25ЊC, the cells of the overlay did not spread as well as at 37ЊC and had a more rounded-up appearance. (12) suggested that at 16ЊC an activated intermediate ternary complex involving gp120-gp41 and CD4 is formed, resulting in increased syncytium formation when the cells were shifted to 37ЊC. At 22ЊC, they found that CD4-induced gp120 shedding inactivated the complex, and less fusion was seen after a shift to 37ЊC. If shedding is significant and faster than fusion, CD4-induced release of gp120 might explain the temperature-dependent fusion effects. To examine this possibility, we overlaid CHO-gp160 cells with SupT1 cells, incubated them at 25ЊC for 3 h, and then shifted them to 37ЊC. No syncytium formation was observed during the 3 h of incubation at 25ЊC. However, syncytium formation began immediately after the temperature was raised to 37ЊC. Furthermore, the rate and extent of fusion were similar to those seen in cultures that had not been first incubated at 25ЊC (Fig. 2) . Similar observations were made after preincubation at 20ЊC (data not shown). The results indicate that in our system, preincubation did not lead to inactivation of fusion activity.
The lack of CHO-gp160 cell-CD4 cell fusion between 0 and 25ЊC could be due to an intrinsic inability of cells to fuse in this temperature range. Influenza virus is able to fuse efficiently with various target membranes, even at 0ЊC (49). For influenza virus-induced fusion of BHK-21 cells carried out as described in Materials and Methods, we found no significant difference between the amounts of fusion triggered by 5 min of incubation at a low pH at 20ЊC (fusion index, 0.92 Ϯ 0.02) and at 37ЊC (fusion index, 0.98 Ϯ 0.1). Control experiments without low-pH incubation showed no fusion. These data are in accordance with the efficient fusion of cells expressing the influenza virus fusion protein with erythrocytes over the 20 to 37ЊC range reported by others (39, 44) , indicating that there is no general block to cell-cell fusion at 25ЊC.
Binding of 125 I-labeled gp120 and CHO-gp160 cells to CD4-expressing cells. For membrane fusion to occur, the membranes involved must first bind to each other. Thus, the temperature dependence of fusion could reflect the temperature dependence of binding of CHO-gp160 cells to SupT1 cells. Binding of soluble CD4 to soluble gp120 shows some decrease with temperature in the 20 to 37ЊC range but is still significant at 20ЊC (8) . Binding of soluble CD4 to cells expressing gp120 was not dependent on temperature in the 4 to 37ЊC range (12) . To see if binding of gp120 to CD4-expressing cells was affected by temperature, gp120 prepared from CHO cells was radioiodinated and its binding to CD4 was measured on SupT1 cells. The 125 I-labeled gp120 preparation was found to bind specifically to cell surface CD4 with an affinity of approximately 2 nM, determined as described in Materials and Methods, at 37ЊC. As a control for nonspecific binding, 125 I-labeled gp120 was incubated with the cells in the presence of a 20-fold molar excess of Q4120, an antibody against CD4. Specific binding was found in the range of 4 to 37ЊC (Fig. 5) . Although there was only half as much binding at 4ЊC as at 37ЊC, the binding at 16ЊC was equivalent to that measured at 37ЊC, indicating that binding of gp120 to CD4-expressing cells is not affected significantly in the 16 to 37ЊC temperature range.
However, cell-cell binding mediated by the interaction of gp120 and CD4 present on cell membranes could involve multiple gp120-CD4 interactions that might exhibit cooperative, temperature-dependent properties. To examine cell-cell binding, BODIPY-FL C 11 -labeled SupT1 cells were added to CHO-gp160 cells on dishes or coverslips and incubated at the desired temperature for 3 to 5 h. The unbound cells were washed away, the remaining cells were lysed with 1% Triton X-100, and the BODIPY-FL C 11 fluorescence was measured. Nonspecific binding of labeled SupT1 cells to the parental CHO K1 cell line was also measured. Specific binding of SupT1 cells to CHO-gp160 cells, compared to CHO K1 cells, was observed over the entire temperature range (Fig. 6) . However, the signal increased three-to fourfold over the temperature range in which fusion took place (Fig. 3) . Binding could be reduced to the level of CHO K1 cells by addition of soluble CD4 (50 g/ml) if it was added to the CHO-gp160 cells 1 h before the experiment (Fig. 6) . Specific binding could also be reduced 70% by addition of anti-CD4 antibody Q4120. The level of SupT1 cells bound to CHO K1 cells represented a true background level, as it was also observed when fluorescently labeled RPMI cells which did not express CD4 were used. By using radioiodinated antibodies against CD4, it was found that cell surface expression of CD4 was not down-regulated for at least 72 h at 25ЊC (data not shown). We do not have a precise quantitative assay for cell surface expression of gp120. However, the cell surface expression of gp120 is slow and inefficient (3, 16, 58) , and therefore, knowing that the fusion activity of CHO-gp160 cells at 37ЊC was not delayed after incubation of the cells for several hours at 25ЊC (Fig. 2) , we think that the expression of gp120 at 25ЊC was not changed Fig. 6 . Thus, the temperature dependence of fusion correlates with the temperature dependence of gp120-CD4-mediated cell-cell binding.
In the cell-cell binding experiments described above, the fluorescence measured at the temperatures at which fusion takes place could come both from bound fluorescent SupT1 cells and from SupT1 cells that had bound to and subsequently fused with CHO-gp160 cells. At these temperatures, many bound but unfused cells could be seen with a microscope (cf. the 2-h time point in Fig. 4) , indicating that the fluorescence was not just from cells that had already fused. Precise quantitation of the bound cells by microscopy was difficult against the background of fluorescent syncytia, but it could be seen that the number of SupT1 cells remaining bound to CHO-gp160 far exceeded that of SupT1 cells bound to CHO K1. To distinguish fusion from binding more clearly, binding experiments were carried out with monoclonal antibodies against the V3 loop of gp120. These antibodies inhibit fusion but do not interfere with CD4-gp120 binding (9) . We found that syncytium formation at 37ЊC was inhibited by 63% Ϯ 9% in the presence of the antibodies. In contrast, fluorescence was not significantly affected, suggesting that similar levels of binding occur even though fusion is inhibited (Fig. 7) . Similarly, at temperatures at which fusion does not take place, similar levels of binding were recorded in the presence and absence of anti-V3 antibodies (Fig.  7) . Together, these data indicate that (i) for a given temperature, similar levels of binding occur regardless of whether the cells proceed to fusion, and (ii) the fluorescence measured under these conditions provides an accurate estimate of cellcell binding whether or not fusion takes place.
The temperature dependence of binding shown in Fig. 6 resembles that observed in the adhesion of cells to substrates such as serum-coated glass (23) or the extracellular matrix protein fibronectin (30) . In these cases, substrate-specific binding, although found at all temperatures, is increased markedly at higher temperatures. At those temperatures, cells can increase the area over which they make contact with the substrate and the additional adhesion molecules which are brought into contact to increase the avidity of binding (30) . An intact cytoskeleton is a prerequisite for this adhesion strengthening (30) . To investigate if a related phenomenon is involved in HIV-mediated syncytium formation, fusion between HeLa-CD4 and CHO-gp160 cells (Table 2) or between SupT1 and CHO-gp160 cells (Table 3) was measured in the absence and presence of cytochalasin B, an agent that reversibly disrupts microfilaments. With both types of target cells, it was found that cytochalasin B reduced both binding and fusion. The effect of cytochalasin B on fusion was reversible. To exclude the possibility that the drug interfered with fusion directly rather than with the cytoskeleton, experiments were repeated with b ND, not done. c After overnight incubation in the presence of cytochalasin B as described in footnote a, the medium was carefully aspirated, replaced with fresh medium without cytochalasin, and then incubated for an additional 16 h.
d A number of cells containing two nuclei, which apparently resulted from synchronized cell division after cytochalasin washout, were seen. cytochalasin D, a related molecule which has similar effects on microfilaments. Similar results were observed with both cytochalasin D and cytochalasin B (Table 3) . Thus, it appears that critical interactions between CHO-gp160 and CD4-positive cells that lead to cell-cell fusion and syncytium formation are enhanced through temperature-dependent functions of the microfilament cytoskeleton. These changes most likely involve an increase in the area of contact between fusing cells, leading to additional interactions between gp120 and CD4 molecules.
DISCUSSION
Enveloped animal viruses enter host cells by membrane fusion (32) . Here, we studied the fusion of cells expressing the HIV-1 fusion protein complex, gp120-gp41, with CD4-bearing cells as a model of the membrane fusion activity of HIV-1. Syncytium formation, dependent on specific CD4-gp120 recognition, was found at 37ЊC. At 25ЊC and below, there was no cell-cell fusion, as evidenced by (i) the lack of syncytium formation and (ii) the lack of transfer of fluorescent phospholipids from labeled CD4-positive cells to unlabeled CHO-gp160 cells. CD4-gp120-specific cell-cell binding occurred over the entire 0 to 37ЊC temperature range but increased three-to fourfold above 25ЊC. Thus, the temperature dependence of binding showed a marked correlation with that of fusion. The binding of soluble gp120 to CD4-expressing cells did not show an increase between 16 and 37ЊC. Both fusion and cell-cell binding were affected by agents that disrupt the cellular microfilament system. Together, these data suggest that after the initial binding of CD4-positive cells to CHO-gp160 cells, there is a cytoskeleton-dependent increase in the avidity of cell-cell binding, most likely resulting from the formation of additional gp120-CD4 contacts, and that the formation of these contacts is a prerequisite for fusion, as was suggested previously (28) .
In these experiments, we used both a syncytium formation assay as an indicator of fusion and an assay based on the transfer of fluorescent phospholipids. As syncytium formation involves not only fusion but also major structural reorganization in the fused cells, the latter assay provided an indicator of fusion without the need for subsequent reorganization. Octadecylrhodamine is frequently used to assay fusion, but we found that molecular exchange of the probe between cells gave rise to false-positive signals in the absence of fusion, especially after long incubations (20 to 60 h), as was found with a number of other membranes (48) . The BODIPY-based assay described here can be used for qualitative assessment of fusion and to detect early or rare fusion events with no detectable molecular exchange. In addition, it provided a convenient quantitative assay for cell-cell binding. However, it is not a quantitative kinetic assay because the fluorescence of the probe is partially quenched by proteins and because all cellular membranes were labeled, not just the plasma membrane.
Since neither the BODIPY assay nor counting of syncytia revealed any fusion between gp120-gp41-expressing cells and CD4-bearing cells, even after very long incubations (60 h to 5 days) at 25ЊC, there seemed to be a genuine temperature threshold for fusion in this system. Furthermore, the temperature dependence we observed is similar to that reported by Fu et al. (12) . By using BJAB cells transfected with an HIV-1 env gene (BH10 strain), they found syncytium formation with SupT1 cells at 37ЊC but not at 22ЊC and below. In addition, fusion was reduced if cells were preincubated together at 22ЊC before a shift to 37ЊC. They concluded that gp120 dissociation from gp41 during the 22ЊC preincubation could account for the reduced fusion activity. In our system, both the rate and extent of fusion were unaffected by preincubation at 25ЊC (Fig. 2) or 20ЊC. Although we did not measure CD4-induced gp120 shedding in this study, the data indicate that any shedding that does occur has no impact on fusion activity. We argue below that the temperature dependence of fusion appears to involve the formation of additional CD4-gp120 interactions and that these interactions occur only at temperatures above 25ЊC.
Fusion of a number of enveloped viruses, such as Semliki Forest virus (5), influenza virus (49), vesicular stomatitis virus (6), and rabies virus (13) , with cells or model membranes has been reported to occur over a broad temperature range (0 to 37ЊC). In contrast, fusion of Sendai virus (21, 59 ) and Rous sarcoma virus (14) with cells, measured by kinetic assays, displays an apparent temperature dependence for fusion with a sharp break at around 20ЊC. However, as pointed out by Yeagle (59) , if the data for Sendai virus are plotted in an Arrhenius plot rather than in a linear fashion, there is no obvious discontinuity, suggesting that there is no threshold temperature for fusion. Preliminary infectivity studies with HIV-1 suggest that viral fusion is inhibited at 20ЊC and below (41a). Nevertheless, in the absence of reliable kinetic data, it may be difficult to judge whether there is a real threshold temperature for HIV-induced fusion.
The temperature dependence of cell-cell fusion induced by viral glycoproteins could be different from that of virus-cell fusion. Generally, fusion of cells plated on dishes cannot be measured below 20ЊC because the cells tend to round up and lose contact. Efficient fusion of influenza virus fusion protein (HA)-expressing cells with erythrocytes occurs over a 20 to 50ЊC temperature range. However, as with virus-cell fusion, erythrocyte fusion is slower at lower temperatures (39, 44) . In contrast, Sendai virus-induced cell-cell fusion is reduced by 85% at 25ЊC compared with 37ЊC but virus-cell fusion is decreased by only 20% (1). Thus, the temperature dependences of virus-cell and cell-cell fusions seem to differ in at least one system and may depend on the nature of the cofactors involved in triggering the fusion activity.
Cell-cell fusion and virus-cell fusion are complex multistep processes of which we know very little, and several steps in the fusion reaction are influenced by temperature. Here we have shown that cell-cell binding is influenced by temperature and, as a consequence, cell-cell fusion is also influenced. Other studies have focussed on one important aspect of this binding, ) labeled with BODIPY-FL C 11 were added to CHOgp160 or CHO K1 cells on coverslips in the presence or absence of cytochalasin B or D and kept at 37ЊC for 3 h. After being washed with PBS 2ϩ , the cells were either lysed with Triton X-100 for determination of fluorescence as described in Materials and Methods or fixed with methanol, stained, and counted as described in the legend to Fig. 2 . After fluorescence determination, the protein concentration of the samples was measured and binding data were corrected accordingly. The fluorescence came from SupT1 cells that were bound to CHO cells but remained unfused, as well as from cells that fused.
b ND, not done. (12) . Furthermore, the temperature dependence of virus neutralization by soluble CD4 was found to depend on the passage history of the virus strains (36, 37, 40) . Given these observations, it is important to realize that a variety of parameters can influence the process. Fusion induced by viral proteins involves a series of sequential reactions that begins with the binding of two opposing membrane systems. Subsequently, conformational changes in the fusion protein, the formation of higher-order multimeric fusion complexes, and the final merging of the two opposing lipid bilayers are required to complete the fusion reaction (57) . Each and all of these steps could be influenced by temperature. For example, temperature has been shown to affect the mobility of cell surface Sendai and influenza virus fusion proteins, thereby affecting the rate of cell-cell fusion, probably because it changes the rate of fusion complex formation (1, 15, 20) . The results presented in this report showing that CD4-gp120-specific cell-cell fusion is both temperature and cytochalasin sensitive suggest that mobility of the plasma membranes of the cells is required for fusion. Most likely, mobile plasma membranes can increase the surface area over which they contact each other, leading to an increase in the number of CD4-gp120 contacts. Alternatively, the lateral mobility of CD4 and/or gp120 may be involved. CD4 may be coupled directly to cytoskeletal elements (see below) and an intact cytoskeleton would therefore be required for the mobility of CD4 and thus also be required for the formation of additional CD4-gp120 contacts. Moreover, it was recently shown that the lateral diffusion of some integral membrane proteins that are not directly linked to cytoskeletal elements was affected by the presence of other membrane proteins, which were linked to the cytoskeleton (43, 60) . This occurred because the latter sterically hindered the former from diffusing randomly in the membrane, in fact confining them to compartments in the membrane most of the time (43, 60) . The requirement for additional CD4-gp120 contacts may reflect the assembly of a functional fusion complex composed of multiple gp120-gp41 and CD4 molecules (28) and perhaps also other adhesion molecules. Plasma membrane mobility and protein lateral mobility can therefore affect the rate of fusion complex formation. Fusion of cells bearing the Sendai virus fusion protein with other cells can also be inhibited by cytochalasin D (34), so it may be that a similar phenomenon is important there also, in line with recent suggestions by Haywood (18) .
Although cell-cell fusion was temperature dependent for HIV gp120-gp41, it was not for influenza virus HA. This could reflect a difference between the concentration of the proteins involved; if the concentration of gp120-gp41 on the cell surface is less than that of HA, additional gp120-gp41 but not HA would need to be recruited from elsewhere on the cell surface to form a fusion complex. However, we have not found a situation in which low concentrations of cell surface HA exhibit temperature-dependent cell-cell fusion (14a). Moreover, Sendai virus fusion protein-induced cell-cell fusion is inhibited by cytochalasin D, even at very high concentrations of viral fusion proteins (34) . Thus, differences in the concentrations of fusion proteins or their receptors do not obviously account for the observed difference between HA-and gp120-gp41-mediated fusions. More likely, these variations reflect inherent differences between the fusion mechanics of the two proteins. Whether it is a coincidence that the viral fusion proteins known to fuse cells in a temperature-or cytoskeleton-dependent manner are pH independent for fusion whereas those that are not cytoskeleton dependent fuse at low pHs remains to be established.
Additional binding events between cells increase the avidity of cell-cell interaction. This phenomenon has been termed adhesion strengthening and is commonly observed in the attachment of cells to surfaces coated with serum or extracellular matrix components (23, 30) . Specific binding involving cellular adhesion molecules occurs at low temperatures. However, additional contacts that increase binding avidity can be formed when the temperature is raised, provided the cytoskeleton is intact (27, 30) . In one example, the avidity of cells binding to fibronectin, but not to tenascin, was increased more than an order of magnitude at 37ЊC compared with 4ЊC, and this increase was inhibited by cytochalasin B (30) . In addition, the cell surface area in contact with the substrate was increased 125-fold (30) . Whether the microfilament integrity is required to stabilize adhesive interactions, to assist in cell spreading, or because the adhesion molecules are attached to cortical actin filaments associated with the plasma membrane is unclear. It has been suggested that adhesion strengthening could be required for viral fusion (18) . Some viruses attach to cell and model membranes in a weak and reversible fashion at low temperatures, whereas they bind more tightly and fuse with the membranes at higher temperatures (18) . Although the data presented in this report are compatible with this idea, is it not entirely clear how microfilament integrity could be linked to the process of viral envelope protein-mediated cell-cell adhesion and fusion. However, it is perhaps significant that CD4-major histocompatibility class II antigen-dependent cell-cell binding shows a similar temperature and cytoskeleton dependence (24) . It has been suggested that CD4 may couple to the cortical cytoskeleton through p56 lck (41) . However, p56 lck is not expressed in HeLa-CD4 cells and there is no evidence that CD4 itself or HIV-1 gp120-gp41 interacts with the actin cytoskeleton. In the absence of additional information on how adhesion strengthening could influence fusion, it seems more likely that the increase in the avidity of binding results from additional CD4-gp120 contacts, which are required for the formation of an active fusion complex, as suggested by Layne et al. (28) .
